United States===Center for Biologics Evaluation and Research
Tracked across 1 events · 69 articles · First seen Feb 10, 2026 · Last active Feb 20, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Regulatory
The United States===Center for Biologics Evaluation and Research (CBER), a division of the United States===Food and Drug Administration (FDA), made the decision to refuse Moderna's application. Moderna's CEO, Stéphane Bancel, noted that the trial design had been discussed and agreed upon with CBER prior to starting.
Feb 10, 2026 · 69 articles
NEWSDESK
Track United States===Center for Biologics Evaluation and Research live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard